LRMR Stock Price
Larimar Therapeutics, Inc.
$1.99
-$0.00(-0.25%)
36
Overall
60
Value
36
Tech
13
Quality
Market Cap
$206.21M
Volume
1.69M
52W Range
$2.61 - $6.42
Target Price
$14.40
LRMR stock price is $1.99 (-0.25% on the day), giving Larimar Therapeutics, Inc. a market cap of $206.21M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
LRMR Stock Overview
- Price
- $1.99
- Previous close
- $1.99
- Open
- $2.05
- Market cap
- $206.21M
- P/E ratio
- -1.2
- 52-week range
- $2.61 - $6.42
- 1-year price target
- $14.40
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 36
About Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LRMR | $1.99 | -0.3% | 1.69M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Larimar Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW